10th Apr 2015 07:49
LONDON (Alliance News) - Tekcapital PLC said Friday it has acquired from Purdue University an exclusive license for a patent-pending technology to measure glucose in breath.
The acquisition adds to Tekcapital's portfolio of patents for non-invasive measurement of glucose, having last Thursday acquired a license for the measurement of glucose in saliva from Arizona State University.
"This technology strengthens our portfolio of IP for the non-invasive measurement of glucose and we look forward to commercialising it with one or more leading medical device companies that can benefit by making it easier and painless for professionals to measure glucose in their patients and for health screening applications," said Executive Chairman Clifford Gross in a statement.
No financial details were disclosed.
Shares in Tekcapital are trading down 0.5% at 21.15 pence Friday morning.
By Hana Stewart-Smith; [email protected]; @HanaSSAllNews
Copyright 2015 Alliance News Limited. All Rights Reserved.
Related Shares:
TekCapital